Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,080.00
0.00 (0.00%)
Last updated: Aug 14, 2025

Yungjin Pharm. Company Description

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products.

The company also provides vitamins, minerals, and other products; and APIs. Yungjin Pharm.

Co., Ltd. was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm.

Co., Ltd. operates as a subsidiary of KT&G Corporation.

Yungjin Pharm. Co., Ltd.
Country South Korea
Founded 1952
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 574
CEO GiSu Lee

Contact Details

Address:
Jamsil Company Building
Seoul, 05510
South Korea
Phone 82 2 2041 8200
Website yungjin.co.kr

Stock Details

Ticker Symbol 003520
Exchange Korea Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency KRW
ISIN Number KR7003520004
SIC Code 2834

Key Executives

Name Position
GiSu Lee Chairman of the Board of Directors, President and Chief Executive Officer
ByeongHo Park Chief Financial Officer and MD
UngYeol Yang MD and GM of Sales HQ
Joongyoun Cho MD and Global Headquarters GM
HongJun Park Managing Director
UngGyu Lee Vice President